Oncosec Medical (ONCS) Misses Q4 EPS by 82c

Oncosec Medical (NASDAQ: ONCS) reported Q4 EPS of ($1.06), $0.82 worse than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Oncosec Medical (ONCS) click here.

You May Also Be Interested In

• Klarna Group plc (KLAR) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY26 Revenue Guidance
• Norwegian Cruise Line Holdings (NYSE: NCLH) PT Raised to $20 at UBS
• VNET Group (VNET) Misses Q2 EPS by 164c